Dr. Christopher Gilmore and team performed the milestone 50,000th SPRINT PNS implant.
CLEVELAND, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the ...
Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
CLEVELAND, Dec. 12, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc. today announced the final patient was enrolled in the RESET Clinical Trial of SPRINT ® PNS for the treatment of chronic low back ...
“This study and the clinical outcomes seen by participants are important measures in better addressing head pain for patients,” said Maria Bennett, President, CEO, and Founder of SPR. “Successfully ...
CLEVELAND, May 21, 2025 (GLOBE NEWSWIRE) -- Today, SPR announced the publication of the MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Study, which evaluates the use of 60-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results